BIOMARIN PHARMACEUTICAL INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q2 2024.
  • Biomarin Pharmaceutical Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 190M shares, a 1.15% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 188M shares, a 1.39% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 185M shares, a 1.32% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 183M shares, a 1.13% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 190M +2.17M +1.15% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 189M +2.2M +1.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 188M +2.57M +1.39% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 188M +2.62M +1.41% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 188M +2.69M +1.45% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 187M +2.68M +1.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 185M +2.41M +1.32% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 186M +2.38M +1.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 185M +2.41M +1.32% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 184M +2.22M +1.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 183M +2.05M +1.13% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 183M +2.07M +1.14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 183M +2.12M +1.17% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 182M +1.87M +1.04% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 181M +1.77M +0.99% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 181M +1.85M +1.03% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 181M +1.68M +0.94% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 180M +1.63M +0.91% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 179M +1.98M +1.12% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 179M +1.81M +1.02% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 179M +2.18M +1.23% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 178M +2.34M +1.33% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 177M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 177M +2.38M +1.36% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 177M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 176M +3.22M +1.87% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q3 2017 175M +7.39M +4.41% Jul 1, 2017 Sep 30, 2017 10-Q 2017-10-31
Q1 2017 173M Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q3 2016 168M +6.83M +4.24% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q4 2015 160M +13.7M +9.35% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 161M +13.9M +9.43% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 160M +14.3M +9.78% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-05
Q1 2015 158M +13.6M +9.47% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-05
Q4 2014 146M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 147M +6.22M +4.42% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 146M +6.72M +4.82% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 144M +16M +12.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 141M Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 139M +21.5M +18.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 128M +12.9M +11.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q2 2012 118M +6.8M +6.12% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 115M +4.42M +3.99% Jan 1, 2012 Mar 31, 2012 10-Q 2012-04-30
Q4 2011 112M +9.03M +8.76% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 112M +10.2M +9.97% Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-31
Q2 2011 111M +9.4M +9.24% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-01
Q1 2011 111M +9.51M +9.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 103M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 102M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 102M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 101M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.